Invention Grant
- Patent Title: Biomarkers for autism spectrum disorders
-
Application No.: US16694314Application Date: 2019-11-25
-
Publication No.: US11254984B2Publication Date: 2022-02-22
- Inventor: Stephen W Scherer , John B Vincent
- Applicant: The Hospital for Sick Children , Centre for Addiction and Mental Health
- Applicant Address: CA Toronto; CA Toronto
- Assignee: The Hospital for Sick Children,Centre for Addiction and Mental Health
- Current Assignee: The Hospital for Sick Children,Centre for Addiction and Mental Health
- Current Assignee Address: CA Toronto; CA Toronto
- Agency: Gowling WLG (Canada) LLP
- Agent Susan Tandan
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883
Abstract:
Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
Public/Granted literature
- US20200157628A1 Biomarkers for Autism Spectrum Disorders Public/Granted day:2020-05-21
Information query
